Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 2: Kinase Target Discovery and Inhibitor Development (Educational Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Introduction
Chairperson: Matthew V. Lorenzi, Ph.D.
Bristol-Myers Squibb, Princeton, NJ
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
Integrative approaches to identify and validate kinase oncogenes
William C. Hahn, M.D., Ph.D.
Dana-Farber Cancer Institute, Boston, MA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
A tale of two oncogenes: Ras and FTIs versus ErbB and Iapatinib
Allen I. Oliff, M.D.
GlaxoSmithKline, Collegeville, PA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
A conceptual framework for multikinase inhibitors
Dr. Patrick Zarrinkar
Ambit Biosciences, San Diego, CA
from 2008 Annual Meeting on April 12, 2008 10:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4